Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions
NCT00970957Phase 3Completed
- Start
- Sep 2009
- Primary completion
- Feb 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in macular edema. Started Sep 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT00970957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00970957.